Notice of Annual Meeting, 17500 [E9-8631]
Download as PDF
<![CDATA[
17500
Federal Register / Vol. 74, No. 71 / Wednesday, April 15, 2009 / Notices
Dated: April 8, 2009.
Carlton Duncan,
Deputy Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–8632 Filed 4–14–09; 8:45 am]
Dated: April 8, 2009.
Carlton Duncan,
Deputy Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–8631 Filed 4–14–09; 8:45 am]
BILLING CODE 3410–16–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Food and Drug Administration
[Docket No. FDA–2009–N–0178]
Notice of Annual Meeting
The Vessel Sanitation Program,
National Center for Environmental
Health, Centers for Disease Control and
Prevention (CDC), announces the
following meeting:
Name: Vessel Sanitation Program:
Annual Program Status Update and
Experience to Date with Program
Operations.
Time and Date: 9 a.m. to 4 p.m., June
12, 2009.
Location: Auditorium, Port Everglades
Administration Building, 1850 Eller
Drive, Fort Lauderdale, Florida 33316.
Status: The meeting is open to the
public, but space is limited. The
meeting room can accommodate
approximately 100 persons. Annual
attendees normally include cruise ship
industry officials, private sanitation
consultants, and other interested
parties.
rwilkins on PROD1PC63 with PROPOSALS
Meeting Objectives
CDC staff will update attendees on the
current status of program topics,
including but not limited to the
following:
• 2008 Program Review.
• Proposed revisions to the Vessel
Sanitation Program Operations Manual
2005.
• Proposed revisions to the Vessel
Sanitation Program Construction
Guidelines 2005.
• Updates on cruise ship outbreaks.
An official record of this meeting will
remain open for 15 days (through June
27, 2009) so that additional materials or
comments may be submitted and made
part of the record.
Advanced registration is encouraged.
You may contact Stephanie Lawrence to
register in advance or to receive
additional information about the
meeting. Ms. Lawrence can be reached
by phone (770–488–3141), fax (770–
488–4127), or e-mail
(slawrence@cdc.gov). Please provide
your name, title, company name,
mailing address, telephone number, fax
number, and e-mail address when
contacting Ms. Lawrence.
VerDate Nov<24>2008
16:44 Apr 14, 2009
Jkt 217001
Preparation for International
Conference on Harmonisation
Meetings in Yokohama, Japan; Public
Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public meeting.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public meeting entitled ‘‘Preparation for
ICH meetings in Yokohama, Japan’’ to
provide information and receive
comments on the International
Conference on Harmonisation (ICH) as
well as the upcoming meetings in
Yokohama, Japan. The topics to be
discussed are the topics for discussion
at the forthcoming ICH Steering
Committee Meeting. The purpose of the
meeting is to solicit public input prior
to the next Steering Committee and
Expert Working Groups meetings in
Yokohama, Japan, scheduled for June 6
through 11, 2009, at which discussion of
the topics underway and the future of
ICH will continue, as well as provide
comprehensive updates of the various
ICH topics.
Date and Time: The meeting will be
held on May 6, 2009, from 2:30 p.m. to
5 p.m.
Location: The meeting will be held in
the Washington Room at the Hilton
Washington DC/Rockville Hotel &
Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
For security reasons, all attendees are
asked to arrive no later than 2:15 p.m.
Contact Person: All participants must
register with Tammie Jo Bell, Office of
the Commissioner (HFG–1), Food and
Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, e-mail:
Tammie.Bell2@fda.hhs.gov, or FAX:
301–827–0003.
Registration and Requests for Oral
Presentations: Send registration
information (including name, title, firm
name, address, telephone, and fax
number), written material and requests
to make oral presentation, to the contact
person by April 29, 2009.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
If you need special accommodations
due to a disability, please contact
Tammie Jo Bell (see Contact Person) at
least 7 days in advance.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at https://www.fda.gov/
ohrms/dockets/ac/acmenu.htm. It may
be viewed at the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD. A transcript will
also be available in either hardcopy or
on CD–ROM, after submission of a
Freedom of Information request. Written
requests are to be sent to Division of
Freedom of Information (HFI–35), Office
of Management Programs, Food and
Drug Administration, 5600 Fishers
Lane, rm. 6–30, Rockville, MD 20857.
SUPPLEMENTARY INFORMATION: The ICH
was established in 1990 as a joint
regulatory/industry project to improve,
through harmonization, the efficiency of
the process for developing and
registering new medicinal products in
Europe, Japan and the United States
without compromising the regulatory
obligations of safety and effectiveness.
In recent years, many important
initiatives have been undertaken by
regulatory authorities and industry
associations to promote international
harmonization of regulatory
requirements. FDA has participated in
many meetings designed to enhance
harmonization and is committed to
seeking scientifically based harmonized
technical procedures for pharmaceutical
development. One of the goals of
harmonization is to identify and then
reduce differences in technical
requirements for medical product
development among regulatory
agencies. ICH was organized to provide
an opportunity for harmonization
initiatives to be developed with input
from both regulatory and industry
representatives. ICH is concerned with
harmonization among three regions: The
European Union, Japan, and the United
States. The six ICH sponsors are the
European Commission; the European
Federation of Pharmaceutical Industries
Association; the Japanese Ministry of
Health, Labor and Welfare; the Japanese
Pharmaceutical Manufactures
Association; the Centers for Drug
Evaluation and Research and Biologics
Evaluation and Research, FDA; and the
Pharmaceutical Research and
Manufacturers of America. The ICH
Secretariat, which coordinates the
preparation of documentation, is
provided by the International
Federation of Pharmaceutical
Manufacturers Associations (IFPMA).
The ICH Steering Committee includes
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 74, Number 71 (Wednesday, April 15, 2009)]
[Notices]
[Page 17500]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8631]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Annual Meeting
The Vessel Sanitation Program, National Center for Environmental
Health, Centers for Disease Control and Prevention (CDC), announces the
following meeting:
Name: Vessel Sanitation Program: Annual Program Status Update and
Experience to Date with Program Operations.
Time and Date: 9 a.m. to 4 p.m., June 12, 2009.
Location: Auditorium, Port Everglades Administration Building, 1850
Eller Drive, Fort Lauderdale, Florida 33316.
Status: The meeting is open to the public, but space is limited.
The meeting room can accommodate approximately 100 persons. Annual
attendees normally include cruise ship industry officials, private
sanitation consultants, and other interested parties.
Meeting Objectives
CDC staff will update attendees on the current status of program
topics, including but not limited to the following:
2008 Program Review.
Proposed revisions to the Vessel Sanitation Program
Operations Manual 2005.
Proposed revisions to the Vessel Sanitation Program
Construction Guidelines 2005.
Updates on cruise ship outbreaks.
An official record of this meeting will remain open for 15 days
(through June 27, 2009) so that additional materials or comments may be
submitted and made part of the record.
Advanced registration is encouraged. You may contact Stephanie
Lawrence to register in advance or to receive additional information
about the meeting. Ms. Lawrence can be reached by phone (770-488-3141),
fax (770-488-4127), or e-mail (slawrence@cdc.gov). Please provide your
name, title, company name, mailing address, telephone number, fax
number, and e-mail address when contacting Ms. Lawrence.
Dated: April 8, 2009.
Carlton Duncan,
Deputy Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-8631 Filed 4-14-09; 8:45 am]
BILLING CODE 4163-18-P
